Southeast Regional Radiation Medical Center and K-MEDI hub Sign Agreement for 'New Drug Development and Radiological Medical Science Research Collaboration'

The Research Center of the Southeast Regional Radiation Medical Institute signed a Memorandum of Understanding (MOU) for strategic cooperation in new drug development and radiation medical science research with the K-MEDI hub (Daegu-Gyeongbuk Medical Innovation Foundation) Preclinical Center on the 13th.

At the signing ceremony held at K-MEDI hub, key officials from both institutions attended and agreed to strengthen cooperation in areas such as ▲discovering and conducting joint research ▲exchange of research human resources ▲joint use of research facilities and equipment.

Following the MOU, a joint seminar was held to explore the development direction of new drug development and radiation medical science research.

In the first session, achievements were introduced including ▲GMP manufacturing of radiopharmaceuticals in the Southeast region and Ga-68 PSMA-11 production (Southeast Regional Radiation Medical Institute Research Center, Manager Taegeon Son) ▲development of disease models using gene editing technology (Southeast Regional Radiation Medical Institute Research Center, Dr. Siho Choi).

In the second session, research results were presented on the topics of ▲Next-generation new drug development: integrated approach of basic research and preclinical trials (K-MEDI hub Preclinical Center, Team Leader Jaeon Lee) ▲Preclinical evaluation using bioimaging (K-MEDI hub Preclinical Center, Senior Researcher Heekyung Kim).

The Southeast Regional Radiation Medical Institute Research Center conducts advanced research in radiation medical science, leading innovation in future medical research through radiation biohealth and radiation life science R&D and establishing an open collaboration system. The K-MEDI hub Preclinical Center is a specialized preclinical institution established to foster the medical industry, a next-generation growth industry, supporting animal experiments, an essential process for the commercialization of medical products such as new drugs and medical devices, for domestic medical R&D institutions.

Park Guseon, Director of K-MEDI hub, stated, “To respond to the rapidly growing global radiation-biotechnology (bio) market, we must discover technologies scattered across industry, academia, research, and hospitals and strengthen a cooperative ecosystem that connects supply and demand. We will actively support multi-faceted cooperation with the Southeast Regional Radiation Medical Institute Research Center to contribute to laying the foundation for radiation bio research and medical industrialization.”

Lee Changhoon, Director of the Southeast Regional Radiation Medical Institute, said, “This strategic cooperation with the K-MEDI hub Preclinical Center will be an important opportunity to further strengthen research capabilities in the field of radiation medical science. Based on the excellent research infrastructure and expertise of both institutions, we will actively cooperate to produce tangible results in new drug development and radiation biohealth, and furthermore contribute to improving public health and advancing national science and technology.”

Joint seminar for collaborative research and mutual exchange. Provided by Dongnam Institute of Radiological & Medical Sciences

This content was produced with the assistance of AI translation services.